Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Pudendal Nerve Block for Pain Relief During Episiotomy Repair

14 novembre 2026 mis à jour par: Zeenat Usman, Shaheed Zulfiqar Ali Bhutto Medical University

Pudendal Nerve Block for Pain Relief During Episiotomy Repair: A Randomized Controlled Trial

Episiotomy is a surgical cut made in the perineum, the area between the vagina and anus, during vaginal childbirth. Repairing an episiotomy can cause pain, and adequate pain relief is important for maternal comfort during and after delivery.

This study will compare two methods of providing anesthesia during episiotomy repair in women undergoing vaginal delivery with a mediolateral episiotomy at the Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.

A total of 80 eligible women will be enrolled and randomly assigned in equal numbers to two groups. The intervention group will receive a bilateral pudendal nerve block in addition to routine episiotomy repair and standard postpartum pain relief. The control group will receive conventional local anesthetic infiltration around the episiotomy area, along with routine repair and standard postpartum pain relief.

Pain will be assessed using a 100-mm Visual Analogue Scale (VAS), on which 0 represents no pain and 100 represents the worst imaginable pain. Pain will be assessed during episiotomy repair and at 1, 3, and 6 hours after delivery.

The study will also compare the need for additional pain medication, pain during sitting and walking, patient comfort and satisfaction, the duration of episiotomy repair, the need for additional local anesthetic, and complications associated with the procedures.

The aim is to determine whether pudendal nerve block provides better pain relief during episiotomy repair and improves early postpartum comfort compared with conventional local anesthetic infiltration.

Aperçu de l'étude

Description détaillée

Episiotomy is a surgical incision of the perineum performed during vaginal delivery and may be associated with pain during repair and in the early postpartum period. Conventional local perineal infiltration is commonly used to provide anesthesia during episiotomy repair; however, adequate pain relief may not always be achieved.

The pudendal nerve supplies sensory innervation to the vulva, lower vagina, perineum, and anus. Pudendal nerve block is a regional anesthetic technique that may provide effective analgesia during episiotomy repair. This study will evaluate the effectiveness of pudendal nerve block compared with conventional local perineal infiltration in women undergoing mediolateral episiotomy at the Department of Maternal and Child Health, Pakistan Institute of Medical Sciences (MCH PIMS), Islamabad.

Eligible women aged 18 years or older who undergo vaginal delivery with mediolateral episiotomy will be recruited after eligibility assessment and informed consent. Participants will be randomly allocated to one of two groups. The intervention group will receive bilateral pudendal nerve block using 2% lidocaine, in addition to routine episiotomy repair and standard postpartum analgesia. The control group will receive conventional local perineal infiltration according to the institutional protocol. Both groups will receive routine episiotomy repair and standard postpartum analgesia.

Pain intensity will be assessed using a 100-mm Visual Analogue Scale during episiotomy repair and at 1, 3, and 6 hours postpartum. Additional assessments will include the need for rescue analgesia, pain during sitting and walking, patient-reported comfort and satisfaction, duration of repair, requirement for additional local anesthetic, and the success or failure of the nerve block. Adverse events and complications associated with the procedures will also be documented.

The study aims to determine whether pudendal nerve block improves pain relief during episiotomy repair and early postpartum comfort compared with conventional local perineal infiltration. The findings may contribute to the local evidence base for pain management during episiotomy repair.

Type d'étude

Interventionnel

Inscription (Estimé)

80

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Zeenat Usman/Medical officier, MS obstetrics and gyanecology
  • Numéro de téléphone: +923315333910
  • E-mail: usmanbut2@gmail.com

Sauvegarde des contacts de l'étude

  • Nom: Sobia Luqman/Assisstant Professor, FCPS obstetrics and gyane
  • Numéro de téléphone: +923348626904
  • E-mail: sobialuqman8@gmail.com

Lieux d'étude

    • ICT
      • Islamabad, ICT, Pakistan, 04485
        • Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS)
        • Contact:
          • Zeenat Usman, MS obstetrics and Gyanecology
          • Numéro de téléphone: +923315333910
          • E-mail: usmanbut2@gmail.com
        • Contact:
          • Sobia Luqman, FCPS obstetrics and gyanecolog
          • Numéro de téléphone: +923348626904
          • E-mail: sobialuqman8@gmail.com
        • Chercheur principal:
          • Zeenat Usman, Ms Obsterics and gyanecology
        • Sous-enquêteur:
          • Sobia Luqman, FCPS-obstertics and gyanecolog
        • Sous-enquêteur:
          • Lubaba Tahir

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 50 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

La description

Inclusion Criteria:

  • Women aged 18 years or older
  • Singleton pregnancy
  • Vaginal delivery at MCH PIMS
  • Requirement for mediolateral episiotomy
  • Clinically uncomplicated episiotomy requiring routine repair
  • Ability to understand the study information and provide written informed consent

Exclusion Criteria:

  • Allergy or contraindication to the proposed local anesthetic
  • Known coagulation disorder or significant bleeding tendency
  • Local infection at the proposed injection site
  • Associated third- or fourth-degree perineal tear
  • Extensive vaginal or cervical laceration requiring additional anesthesia
  • Major postpartum hemorrhage or another major postpartum complication requiring urgent management
  • Chronic pelvic or perineal pain, or regular use of analgesic medication before delivery
  • Inability to understand the pain assessment scale or provide informed consent
  • Failed pudendal nerve block despite appropriate technique

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Pudendal Nerve Block Group

Participants will receive bilateral pudendal nerve block using 2% lidocaine, 2 mL, as specified in the study protocol. The procedure will be performed by an appropriately trained obstetrician or anesthetist using a standardized technique. Routine episiotomy repair and standard postpartum analgesia will also be provided.

Bilateral pudendal nerve block performed using the standardized technique specified in the study protocol, with the local anesthetic described in the protocol (2% lidocaine, 2 mL). The procedure will be performed by an appropriately trained obstetrician or anesthetist, in addition to routine episiotomy repair and standard postpartum analgesia.

Local anesthetic administered for bilateral pudendal nerve block at a dose of 2 mL, as specified in the study protocol.

Comparateur actif: Conventional Local Infiltration Group

Participants will receive conventional local perineal infiltration anesthesia according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will be provided.

Conventional local anesthetic infiltration around the episiotomy site according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will also be provided.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Pain intensity during episiotomy repair
Délai: During episiotomy repair

Pain intensity will be measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 mm represents the worst imaginable pain. Pain will be assessed at predefined stages during episiotomy repair, including after anesthesia administration, at commencement of repair, during repair, and at completion of repair.

During episiotomy repair

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Postpartum pain intensity
Délai: 1, 3, and 6 hours postpartum

pain intensity measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 represents the worst imaginable pain.

1, 3, and 6 hours postpartum
Requirement for rescue analgesia
Délai: First 6 hours postpartum

Proportion of participants requiring additional analgesic medication for inadequate episiotomy-related pain relief.

First 6 hours postpartum
Patient satisfaction with pain management
Délai: 1-6 hours postpartum

Patient satisfaction with pain management assessed using a 5-point Likert scale, ranging from very dissatisfied to very satisfied.

1-6 hours postpartum

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

31 octobre 2026

Achèvement primaire (Estimé)

31 janvier 2027

Achèvement de l'étude (Estimé)

15 février 2027

Dates d'inscription aux études

Première soumission

13 octobre 2026

Première soumission répondant aux critères de contrôle qualité

13 octobre 2026

Première publication (Réel)

20 octobre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

17 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

14 novembre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

De-identified individual participant data collected during this study will not be shared with researchers outside the study team. Study data will be used for the planned analyses and reporting of study findings.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner